Psoriasis: Emerging therapeutic strategies

被引:130
作者
Gottlieb, AB [1 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Clin Res Ctr, New Brunswick, NJ 08901 USA
关键词
D O I
10.1038/nrd1607
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Psoriasis is a chronic inflammatory skin disorder that is characterized by thickened, scaly plaques, and is estimated to affect similar to 1 - 3% of the Caucasian population. Traditional treatments, although effective in patients with limited disease, have numerous shortcomings, including inconvenience and toxicity. These drawbacks mean that many patients experience cycles of disease clearance, in which normal quality of life alternates with active disease and poor quality of life. However, as this review discusses, recent advances have highlighted the key role of the immune system in the pathogenesis of psoriasis, and have provided new defined targets for therapeutic intervention, offering hope for safe and effective psoriasis treatment.
引用
收藏
页码:19 / 34
页数:16
相关论文
共 196 条
[1]  
ABBAS AK, 2003, CELLULAR MOL IMMUNOL, P506
[2]   CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris [J].
Abrams, JR ;
Lebwohl, MG ;
Guzzo, CA ;
Jegasothy, BV ;
Goldfarb, MT ;
Goffe, BS ;
Menter, A ;
Lowe, NJ ;
Krueger, G ;
Brown, MJ ;
Weiner, RS ;
Birkhofer, MJ ;
Warner, GL ;
Berry, KK ;
Linsley, PS ;
Krueger, JG ;
Ochs, HD ;
Kelley, SL ;
Kang, SW .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1243-1252
[3]   Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells [J].
Abrams, JR ;
Kelley, SL ;
Hayes, E ;
Kikuchi, T ;
Brown, MJ ;
Kang, SW ;
Lebwohl, MG ;
Guzzo, CA ;
Jegasothy, BV ;
Linsley, PS ;
Krueger, JG .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (05) :681-693
[4]   ANTIPSORIATIC EFFECT OF FUMARIC-ACID DERIVATIVES - RESULTS OF A MULTICENTER DOUBLE-BLIND-STUDY IN 100 PATIENTS [J].
ALTMEYER, PJ ;
MATTHES, U ;
PAWLAK, F ;
HOFFMANN, K ;
FROSCH, PJ ;
RUPPERT, P ;
WASSILEW, SW ;
HORN, T ;
KREYSEL, HW ;
LUTZ, G ;
BARTH, J ;
RIETZSCHEL, I ;
JOSHI, RK .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (06) :977-981
[5]  
[Anonymous], 1995, Journal of the European Academy of Dermatology and Venereology
[6]  
Antoni C, 2003, ARTHRITIS RHEUM, V48, pS265
[7]  
Antoni C, 2002, ARTHRITIS RHEUM-US, V46, pS381
[8]   IL-10 is a key cytokine in psoriasis -: Proof of principle by IL-10 therapy:: A new therapeutic approach [J].
Asadullah, K ;
Sterry, W ;
Stephanek, K ;
Jasulaitis, D ;
Leupold, M ;
Audring, H ;
Volk, HD ;
Döcke, WD .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :783-794
[9]  
Austin L, 1998, J INVEST DERMATOL, V110, P649
[10]   Intraepidermal lymphocytes in psoriatic lesions are activated GMP-17(TIA-1)+CD8+CD3+CTLs as determined by phenotypic analysis [J].
Austin, LM ;
Coven, TR ;
Bhardwaj, N ;
Steinman, R ;
Krueger, JG .
JOURNAL OF CUTANEOUS PATHOLOGY, 1998, 25 (02) :79-88